Monday, May 26, 2014

Thank you ATS!

Our team is now back in the office and had a wonderful time meeting long time flexiVent and inExpose researchers while also creating new collaborations during the American Thoracic Society's International conference in San Diego last week.

We had a great turnout at our Breakfast Symposium last Monday morning where we discussed how details matter in creating reproducible data throughout your research. This was also shown during our poster session where Dr. Robichaud discussed her findings on aerosol delivery.

We look forward to continuing the conversation and working in collaboration with you throughout the year!

Tuesday, May 13, 2014

Come by and see us at ATS 2014!

We are heading back to San Diego to attend the American Thoracic Society International Conference from May 18-20 and also host a Breakfast Symposium on Monday May 19!

Our booth at ATS 2014

We will be at booth 3823 in the main convention center hall.

Come by and see a live demonstration of our equipment! We will be showing the flexiVent, our integrated platform which combines a mechanical ventilator with detailed measurements of respiratory mechanics, along with both our Multi-Subject extension (MSX) and Negative Pressure Forced Expirations (NPFE) extension. We will also have demonstrations of our inExpose, a compact, cost-efficient bench-top inhalation exposure system. Our team of experts will be there to discuss how we can work together to optimize your research and answer any questions you may have.

Exhibit hours:
Sunday May 18 - 10:30am to 4pm
Monday May 19 - 10:30am to 3pm
Tuesday May 20 - 10:30am to 3pm












Poster

Come by our poster on Tuesday to see our Senior Scientist, Dr. Annette Robichaud, present her latest findings.

Reduced Aerosol Production Associated With Improved Aerosol Delivery To The Subject's Airways [Publication Number: A4976]
Day/Date: Tuesday, May 20, 2014
Poster Viewing: 10:45-12:30
Session Info: Thematic Poster Session, [C62] MUSCLE SPASM AND COUGH: GOT THE NERVE?
Room: Area E (Hall B2-C, Ground Level) Poster Board #E6

Breakfast Symposium

Come and meet us on Monday May 19 at 7am for a discussion on experimental details, their impact on lung function measurements and how they can be accounted for to conduct reproducible research.


Session topic: Details Matter. How Reproducible is your Research?
This event is free of charge.

Space is limited. Click here for details and to register today!

Monday, May 12, 2014

SCIREQ joins the emka TECHNOLOGIES family

MONTREAL, PARIS, May 9th 2014 - We are pleased to announce that emka TECHNOLOGIES has acquired SCIREQ Scientific Respiratory Equipment Inc.

SCIREQ is a leader in the fields of preclinical respiratory research and inhalation exposure. SCIREQ’s products cover a wide range of pulmonary research applications, from the mechanistic study of lung diseases such as asthma and COPD to the development and validation of novel therapeutics approaches.

The flexiVent, SCIREQ’s flagship instrument, is the “gold standard” for in vivo lung function measurements, cited in over 1000 peer-reviewed scientific publications. SCIREQ’s inExpose is a compact, cost-efficient inhalation exposure system allowing precise delivery of inhaled pharmacological compounds and toxins. Details can be found at www.scireq.com.

A STRONG PARTNERSHIP, TWELVE YEARS IN THE MAKING

emka and SCIREQ have been working hand in hand since 2002. Both organizations share a customer-centric approach and create integrated instruments that combine measurement accuracy and reproducibility with user-friendly software and advanced traceability.

Jean-Gérard Napoléoni, CEO of emka, said :

"SCIREQ has built a great team, and developed products providing unique and valuable information about the lungs. We are excited to welcome them to the emka family.”

David Brunet, Vice President of SCIREQ, commented:

"We are thrilled to join emka. This transaction is a testament to the team, products and corporate culture we’ve built over the years. Combined, we can rely on highly specialized team of engineers and scientists, and now have access to an extended network of researchers and sales channels. This will allow us to continue developing world-class research instruments."

SUSTAINED SERVICE

SCIREQ will continue to operate its full team from its head office in Montreal, Canada. We will honor all open quotations and existing service contracts and continue to work closely with the research community to develop new and innovative products and applications.

ABOUT EMKA TECHNOLOGIES

Founded in Paris, France in 1992, emka TECHNOLOGIES designs scientific instruments for physiology, pharmacology and toxicology research. It is an established leader in the pre-clinical instrument market providing an array of innovative products and services for in vivo and in vitro research, and prides itself on offering outstanding customer service. Details may be found at www.emka.fr and www.emkatech.com.

UNPARALLELED KNOW-HOW, WORLDWIDE IMPLANTATION

The integration of SCIREQ and recent hire of experienced staff formerly with BUXCO elevates the EMKA-SCIREQ group as world leader in biomedical research instruments.

With a team of 60 and offices in France, Great-Britain, Spain, Canada, USA, China, Japan and a network of distributors, we offer:

  • The most complete range of pulmonary study systems on the market, backed up by more than 100 years of cumulated experience from our engineers and product specialists;
  • Telemetry solutions for small and large animals;
  • Cardiovascular, isolated organ and heart, and neurology solutions;
  • Software tools (IOX and ecgAUTO) providing the most powerful functionalities in a GLP environment.
  • A well deserved reputation for fast and reliable support and service.
  • Let us help you advance your research; please contact one of our dedicated application specialists today at sales@scireq.com or by calling us toll free at 1.877.572.4737.

    Tuesday, May 6, 2014

    World Asthma Day

    The first Tuesday in May is marked as World Asthma Day by the Global Initiative for Asthma. This day is aimed at spreading awareness about care and how "You Can Control Your Asthma". Thank you to all researchers and health care providers striving to develop effective treatments for this condition that currently affects 235 million people around the world1.

    For more information on World Asthma Day, visit the Global Initiative for Asthma's website.

    1 World Health Organization. "10 facts on Asthma" http://www.who.int/features/factfiles/asthma/en/